BioMaxima S.A.

zł 8.68As of Sun 8 Nov 2026, 12:00 UTC
WSE:BMXHealthcare
Country Poland
PE (Fwd) •••
TSR 10Y CAGR 6.09%
Div yield —
ROE 1.69%
Diagnostics & Research
Beta (5Y) 0.33
PE TTM 44.99
TSR TTM (32.97%)
Mkt cap zł 36.40M
ROIC 1.83%
SE Grade™
Value
Quality
Moat
Consensus
Reference
zł 9.97
14.91%
(54.32%)
Hold 7|9|1|2|5
4Q25
1Q26
2Q26
3Q26
Earnings per sharezł
0.13
0.13
0.12
0.13
1.98%
0.35%
(6.91%)
(3.39%)
Revenuezł M
1.905
2.009
2.107
2.199
3.60%
12.17%
15.68%
14.33%
Peers (US$9.191M)
Cap (US$)
PE
75.84M
—
Capital
TTM
5Y
10Y
Leveragex
1.439
—
—
EBIT/Intx
0.801
0.140
0.120
Own earn%
(12.76)
37.42
33.76
Sh yield%
22.97
60.82
58.22
Owners
Insiders/Inst%
11.53
84.74
Short interest%
5.54
SBC / revenue%
5.66
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
19–25
$1 testx
—
Incr. ROIC%
17